Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference95 articles.
1. Ravandi F, Kantarjian H, Giles F, Cortes J . New agents in acute myeloid leukemia and other myeloid disorders. Cancer 2004; 100: 441–454.
2. Caron PC, Co MS, Bull MK, Avdalovic NM, Queen C, Scheinberg DA . Biological and immunological features of humanized M195 (anti-CD33) monoclonal antibodies. Cancer Res 1992; 52: 6761–6767.
3. Appelbaum FR, Matthews DC, Eary JF, Badger CC, Kellogg M, Press OW et al. The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia. Transplantation 1992; 54: 829–833.
4. Hamann PR, Hinman LM, Hollander I, Beyer CF, Lindh D, Holcomb R et al. Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Bioconjug Chem 2002; 13: 47–58.
5. Hamann PR, Hinman LM, Beyer CF, Lindh D, Upeslacis J, Flowers DA et al. An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker. Bioconjug Chem 2002; 13: 40–46.
Cited by
183 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献